Food-drug interactions

Drugs

Volumn 62, Issue 10, 2002, Pages 1481-1502

  Schmidt, Lars E ^a   Dalhoff, Kim ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADALAT OROS; ALENDRONIC ACID; ANTHELMINTIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; ANTIRHEUMATIC AGENT; AVITRIPTAN; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; CIPROFLOXACIN; CLODRONIC ACID; CYCLOSPORIN A; DERMATOLOGICAL AGENT; DIDANOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETIDRONIC ACID; HALOFANTRINE; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; NEUROLEPTIC AGENT; NIFEDIPINE; NOOTROPIC AGENT; NORFLOXACIN; PENICILLAMINE; TETRACYCLINE; THEOPHYLLINE; UNINDEXED DRUG;

CHELATION; DAIRY PRODUCT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG ELIMINATION; DRUG FORMULATION; DRUG METABOLISM; DRUG SOLUBILITY; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; PHARMACODYNAMICS; REVIEW; RISK ASSESSMENT; STOMACH ACID SECRETION; TOXICITY; TREATMENT FAILURE;

EID: 0036073540     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262100-00005     Document Type: Review

References (268)

1. Drug-food interactions in hospitalised patients. Methods of prevention
2. A new system for grading recommendations in evidence based guidelines
3. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: A potentially life threatening interaction
4. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?
5. Food increases the bioavailability of acitretin
6. Studies of the oral bioavailability of alendronate
7. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics
8. Increased systemic availability of albendazole when taken with a fatty meal
9. Pharmacokinetics of amoxicillin and ampicillin: Crossover study of the effect of food
10. Antimicrobial activity and human pharmacology of amoxicillin
11. Comparative effect of food on absorption of ampicillin and pivampicillin
12. Bioavailability of ampicillin and amoxicillin in fasled and nonfasted subjects
13. The infuence of food on the absorption of antimicrobial agents
14. Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients
15. Atovaquone suspension in HIV-infected volunteers: Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study
16. Relative bioavailability of atovaquone suspension when administered with an enteral nutrition supplement
17. Examination of some factors responsible for a food-induced increase in absorption of atovaquone
18. Clinical toleration and safety of azithromycin
19. Effect of food on the bioavailabidity of captopril in healthy subjects
20. Impairment of captopril bioavadability by concomitant food and antacid in take
21. Influence of food on acute and chronic effects of captopril in essential hypertensive patients
22. Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake
23. Pharmacokinetics of carbamazepine in normal man
24. Effect of dose and food on the bioavailability of cefuroxime axetil
25. Pharmacokinetics and bactericidal activity of cefuroxime axetil
26. Pharmacokinetics of cefuroxime axetil and cefactor: Relationship of concentrations in serum to MICs for common respiratory pathogens
27. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil
28. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food
29. Pharmacologic evaluation of orally administered antibiotics in infants and children: Effect of feeding on bioavailability
30. Interference of dairy products with the absorption of ciprofloxacin
31. Timing of food intake has a marked effect on the bioavailability of clodronate
32. Pharmaeokinetics of clofazimine in healthy volunteers
33. Pharmacokinetics of 2′,3′-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications
34. Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation
35. Food-ioduced reduction in bioavailability of didanosine
36. Decreased bioavailability of digoxin due to hypocholesterolemic interventions
37. Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man
38. Influence of milk on the bioavailability of doxycycline: New aspects
39. Bioavadabdity of erythromycin stearate: Influence of food and fluid volume
40. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate
41. The influence of food on the bioavailability of new formulations of erythromycin stearate and base
42. Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast
43. Influence of food on the absorption of erythromycin from enteric-coated pellets and stearate tablets
44. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food
45. Bioavailability and effect of food on the gastrointestinal absorption of two erythromycin derivatives
46. Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state
47. Effect of food on absorption of erythromycin. A study of two derivatives, the stearate and the base
48. Effect of a high-fat meal on the bioavailability of a polymer-coated erythromycin particle tablet formulation
49. Bioavailability of erythromycin ethylsuccinate in pediatric patients
50. The time of day that etidronate is ingested does not influence its therapeutic effect in osteoporosis
51. Absorption of oral diphosphonate in normal subjects
52. Effect of food on the absorption of frusemide and bumetanide in man
53. The influence of food intake on the effect of two controlled release formulations of furosemide
54. Reduced bioavailability and effect of furosemide given with food
55. Pharmacakinetics of furosemide in man after intravenous and oral adinistration. Application of moment analysis
56. Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons
57. Effect of food on the relative bioavailability of oral ganciclovir
58. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultra-microsize (GRIS-PEG) plain tablets
59. Human pharmacology of griseofulvin: The effect of fat intake on gastrointestinal absorption
60. Effect of feeding on bioavailability of griseofulvin in children
61. Influence of high fat diet on GI absorption of griseofulvin tablets in man
62. Fat contents of meals and bioavailability of griseofulvin in man
63. Pharmacokinetics of halofantrine in man: Effects of food and dose size
64. Concomitant food intake does enhance the bioavailability and effect of hydralazine
65. Effect of food on the absorption of hydralazine in man
66. Influence of food on the bioavadabdity of 'real' and 'apparent' hydralazine from conventional and slow-release preparations
67. Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients
68. Effect of food on blood hydralazine levels and response in hypertension
69. Interactions between hydralazine and oral nutrients in humans
70. Single-dose pharmacokinetics of indinavir and the effect of food
71. Food reduces isoniazid bioavailability in normal volunteers
72. Influence of various diets on the bioavailability of isoniazid
73. Reduction of isoniazid bioavailability in normal men by concomitant intake of food
74. Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids
75. Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide
76. Food increases the bioavailability of isotretinoin
77. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers
78. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
79. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection
80. Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects
81. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraeonazole and fluconazole
82. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers
83. Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole
84. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease
85. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients
86. Effect of meal timing on the kinetic-dynamic profile of levodope/carbidopa controlled release in parkinsonian patients
87. The 'on-off' phenomenon in Parkinson's disease. Relation to levodopa absorption and transport
88. Single-dose pharmacokinetics of Madopar HBS in patients and effect of food and antacid on the absorption of Madopar HBS in volunteers
89. Interaction between fibre and lovastatin
90. Effects of dose and food on HMG-CoA reductase inhibitor profiles after lovastatin (mevacor)
91. Dietary tyramine and other pressor amines in MAOI regimens: A review
92. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs
93. Food increases the bioavailability of mefloquine
94. Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma
95. The effect of food on oral melphalan absorption
96. Influence of food on the bioavailability of oral methotrexate in children
97. Effects of food and gender on the pharmacokinetics of methotrexate in children
98. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?
99. The effect of food on the oral administration of 6-mercaptopurine
100. Oral mercaptopurine in childhood leukemia: Influence of food intake on bioavailability
101. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
102. Effects of food and antacid on oral absorption of misoprostol, a synthetic prostaglandin E1 analog
103. Postprandial administration of prostaglandin (misoprostol) produces less adverse effects on intestinal transit than its preprandial administration
104. Food and nifedipine pharmacokinetics
105. Effect of food ingestion on nifedipine absorption and haemodynamic response
106. Effect of food on nifedipine pharmacokinetics
107. Nifedipine: Kinetics and dynamics after single oral doses
108. Effect of food on nifedipine sustained-release preparation
109. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers
110. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food
111. Effect of milk on absorption of norfloxacin in healthy volunteers
112. Norfloxacin - A review of pharmacology and tissue penetration
113. Ondansetron absorption in adults: Effect of dosage form, food, and antacids
114. Penicillamine kinetics in normal subjects
115. Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate
116. Influence of food on the bioavailability of penicillamine
117. Studies on oral utilization of penicillin V
118. The effect of food on the oral absorption of penicillin V preparations in children
119. Absorption and excretion of four penicillins: Penicillin G, penicillin V, phenethicillin and phenylmercaptomethyl penicillin
120. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum
121. Interference of oral phenytoin absorption by continuous nasogastric feedings
122. Dietary interaction with phenytoin
123. Phenytoin malabsorption after jejunostomy tube delivery
124. Phenytoin and nasogastric feedings
125. Effect of food on pravastatin pharmacokinetics and pharmacodynamics
126. Effect of food on enteral absorption of quinidine
127. Bioavailability of rifampicin capsules
128. Effect of food on bioavailability of rifampicin
129. Effect of meals on rifampicin absorption
130. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids
131. Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood
132. Rifampicin and breakfast
133. The use of pharmacoscintigraphy to elucidate food effects observed with a novel protease inhibitor (saquinavir)
134. Pharmacokinetics of the HIV-protease inhibitor, Ro 318959, after single and multiple oral doses in healthy volunteers
135. Clinical use of potassium supplements and potassium sparing diuretics
136. Hyperkalemia with cardiac arrhythmia. Induction by salt substitutes, spironolactone, and azotemia
137. The temporal effect of food on tacrine bioavailability
138. Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects
139. The influence of coffee with milk and tea with milk on the bioavailability of tetracycline
140. Absorption of minocycline hydrochloride and tetracycline hydrochloride. Effect of food, milk, and iron
141. Interactions with the absorption of tetracyclines
142. Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects
143. Food-induced 'dose-dumping' from a once-a-day theophylline product as a cause of theophylline toxicity
144. Food-induced changes in theophylline absorption from controlled-release formulations. Part 1. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle
145. Food induced changes in theophylline absorption from a once-a-day theophylline product
146. Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, food
147. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment
148. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto
149. Effect of enteral nutrition on warfarin therapy
150. Acquired warfarin resistance and weight-reducing diet
151. The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients
152. The effect of timing of a standard meal on the pharmacokinetics and pharmacodynamics of the novel atypical antipsychotic agent ziprasidone
153. Pharmacokinetics of Cp-88,059 (CP) in healthy male volunteers following oral (PO) and intravenous (IV) administration
154. Influence of food intake on the bioavailability of zuclopenthixol
155. Effects of food on clinical pharmacokinetics
156. Physiochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH
157. Drug-grapefruit juice interactions
158. Absorption and disposition of warfarin: Effect of food and liquids
159. Warfarin antagonism by avocado
160. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states
161. Effect of a standard breakfast on digoxin absorption in normal subjects
162. Plasma concentrations of digoxin after oral administration in the fasting and postprandial state
163. Pharmacokinetic interactions with digoxin
164. Influence of food on the comparative bioavailability of a fast- and slow-release dosage form of quinidine gluconate
165. Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tablet
166. Effect of food and an antacid on quinidine bioavailability
167. Enhancement of hydralazine bioavailability by food
168. The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard)
169. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine
170. Interaction of citrus juices with felodipine and nifedipine
171. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects
172. The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil
173. The influence of food on the pharmacokinetics and ACE inhibition of cilazapril
174. Influence of food on the bioavailability of enalapril
175. Effect of food on the bioavailability of lisinopril, a nonsulfhydryl angiotensin-converting enzyme inhibitor
176. Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor
177. Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
178. Fluvastatin administration at bedtime versus with the evening meal: A multicenter comparison of bioavailability, safety, and efficacy
179. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid
180. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin
181. Grapefruit juice-simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors
182. Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children
183. Effect of structured dietary fiber on bioavailability of amoxicillin
184. Absorption of pivampicillin as related to dose, and tolerability of a 700 mg tablet
185. Bioavailability of cephalexin in children: Relationship to drug formulations and meals
186. Cephalexin: Human studies of absorption and excretion of a new cephalosporin antibiotic
187. Influence of food on the bioavailability of roxithromycin versus erythromycin stearate
188. Influence of food on absorption of erythromycin ethyl succinate
189. Effect of food on absorption and hydrolysis of erythromycin acistrate
190. Effect of concomitant food intake on absorption kinetics of erythromycin in healthy volunteers
191. Lack of effect of food on the bioavailability of oral azithromycin tablets
192. The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension
193. Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial
194. Roxithromycin: A pharmacokinetic review of a macrolide
195. The effects of grapefruit juice on the pharmacokinetics of erythromycin
196. Effect of grapefruit juice on clarithromycin pharmacokinetics
197. Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin
198. Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast
199. Pharmacokinetics and bioavailability of ciproxin and ofloxacin: Effect of food and antacid intake
200. The pharmacokinetics of ofloxacin in healthy adult male volunteers
201. The effect of food on the pharmacokinetics of ofloxacin
202. The effect of food or milk on the absorption kinetics of ofloxacin
203. Milk and yoghurt do not impair the absorption of ofloxacin
204. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin
205. Influence of food on the pharmacokinetics of ketoconazole
206. Disposition of ketoconazole, an oral antifungal, in humans
207. Impairing effect of food on ketoconazole absorption
208. Effect of food and gastric acidity on absorption of orally administered ketoconazole
209. The effect of coadministration of a cola beverage on the bioavailability of itraconazole in patients with acquired immunodeficiency syndrome
210. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole
211. Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole
212. Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects
213. Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers
214. Isoniazid and reaction to cheese
215. Isoniazid interactions
216. Effect of food on ethambutol absorption
217. Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids
218. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children
219. Prolonged, but not diminished, zidovudine absorption induced by a high- fat breakfast
220. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal
221. Pharmacokinetics of 3TC (GR109714X) administered with and without food to HIV-infected patients
222. Lamivudine/zidovudine as a combined formulation tablet: Bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption
223. Abacavir/lamivudine/zidovudine as a combined formulation tablet: Bioequivalence compared with each component administered concurrently and the effect of food on absorption
224. Can food affect the bioavailability of chlorambucil in patients with haematological malignancies?
225. Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard
226. The effects of food on methotrexate absorption
227. The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers
228. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis
229. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals
230. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients
231. Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in kidney transplant recipients
232. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration
233. Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine
234. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: Does the formulation difference matter?
235. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice
236. Food interactions affecting the absorption of analgesic and anti-inflammatory agents
237. The effect of food on the absorption of phenytoin
238. Influence of food on the absorption of phenytoin in man
239. Effect of simultaneously ingested milk on phenytoin bioavailability
240. Influence of food on the bioavailability of a carbamazepine slow-release formulation
241. The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation
242. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy
243. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers
244. The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers
245. Protein intake and treatment of Parkinson's disease with levodopa
246. 'On-off' phenomenon in Parkinson's disease: Relationship between dopa and other large neutral amino acids in plasma
247. Dietary influences on the antiparkinsonian response to levodopa
248. Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa
249. Side effects of isocarboxazid
250. Serum concentrations of mebendazole in patients with hydatid disease
251. Influence of diet and fluid on bioavailability of theophylline
252. Food effects on the nighttime pharmacokinetics of Theo-Dur tablets
253. The influence of food on the bioavailability of a slow release theophylline preparation
254. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet
255. Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation
256. Influence of food on the absorption of theophylline administered in the form of sustained release tablet and microgranules
257. Study on the influence of food on the absorption of theophylline from a controlled-release preparation
258. Food interaction study of a new theophylline (Egifilin) 200 and 400 mg retard tablet in healthy volunteers
259. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet
260. Food interactions with sustained-release theophylline preparations. A review
261. Theophylline disposition after single-dose ingestion of a once-a-day preparation (Dilatrane A. P. 400 mg) with and without breakfast
262. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system
263. Kinetics of absorption of a new once-a-day formulation of theophylline in the presence and absence of food
264. Grapefruit juice-terfenadine single-dose interaction: Magnitude, mechanism, and relevance
265. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine
266. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram
267. Drug interactions with grapefruit: Whose responsibility is it to warn the public?
268. Grapefruit juice-drug interactions